Carr Patricia — SEC insider filings
SEC reporting owner CIK 1784606. 31 insider filings on record with FilingPulse; latest filed 2026-11-06.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2020-08-11 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 38 legs across 25 filings — 35,417 shares, $5,669,144 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 5,250 shares @ $182.07 ($955,868) in Jazz Pharmaceuticals plc, filed 2025-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | 31 | — | 38 legs · 35,417 sh · $5,669,144 | 25 |
Insider filings — Carr Patricia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 1,250 @ $140.03 · Sale (S): 1,250 @ $231.37 · Sale (S): 163 @ $231.27 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,436 @ $186.77 · Sale (S): 1,287 @ $182.94 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,223 @ $0 · Sale (S): 1,253 @ $194.11 · Sale (S): 1,117 @ $190.91 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,370 @ $0 | EDGAR |
| 2025-12-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 160 @ $171.11 · Option exercise (M): 4,500 @ $140.67 · Sale (S): 4,500 @ $171.20 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 69 @ $181.66 · Option exercise (M): 5,250 @ $136.18 · Sale (S): 5,250 @ $182.07 · Option exercise (M): 5,250 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 1,333 @ $138.23 · Sale (S): 1,140 @ $137.81 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 4,500 @ $113.10 · Sale (S): 4,500 @ $144.42 · Option exercise (M): 313 @ $123.36 · Sale (S): 313 @ $144.42 · Disposition to issuer (D): 371 @ $142.43 · Disposition to issuer (D): 497 @ $142.43 · +4 more | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,641 @ $0 | EDGAR |
| 2024-12-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 53 @ $122.49 | EDGAR |
| 2024-06-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 163 @ $108.83 | EDGAR |
| 2024-03-08 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,236 @ $120.85 · Sale (S): 700 @ $117.51 · Sale (S): 1,768 @ $116.98 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,987 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,327 @ $0 | EDGAR |
| 2023-08-31 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 142 @ $143.47 | EDGAR |
| 2023-08-15 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 158 @ $138.16 | EDGAR |
| 2023-06-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 126 @ $127.92 | EDGAR |
| 2023-03-17 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,023 @ $133.22 | EDGAR |
| 2023-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,523 @ $0 · Sale (S): 1,148 @ $140.76 | EDGAR |
| 2022-12-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 63 @ $152.06 | EDGAR |
| 2022-08-17 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 142 @ $156.86 · Option exercise (M): 2,000 @ $113.10 · Sale (S): 2,000 @ $160.29 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2022-08-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 158 @ $152.33 | EDGAR |
| 2022-06-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 131 @ $150.26 | EDGAR |
| 2022-05-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,056 @ $148.93 · Sale (S): 11 @ $150.49 · Sale (S): 273 @ $144.18 · Sale (S): 722 @ $147.51 | EDGAR |
| 2022-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,488 @ $0 | EDGAR |
| 2021-08-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 157 @ $147.96 | EDGAR |
| 2021-03-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,089 @ $161.61 · Sale (S): 961 @ $161.50 | EDGAR |
| 2021-03-01 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,895 @ $0 | EDGAR |
| 2020-12-08 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 62 @ $152.55 | EDGAR |
| 2020-08-14 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 142 @ $123.80 | EDGAR |
| 2020-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 158 @ $125.87 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1784606 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs